{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:21:53Z","timestamp":1790295713371,"version":"4.1.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T00:00:00Z","timestamp":1402876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2014.00220","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T11:55:23Z","timestamp":1402919723000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Neuronal and hormonal perturbations in postural tachycardia syndrome"],"prefix":"10.3389","volume":"5","author":[{"given":"Philip L.","family":"Mar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish R.","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1161\/ATVBAHA.111.244343","article-title":"Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome","volume":"32","author":"Bayles","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1161\/01.CIR.0000147280.90339.E9","article-title":"Sympathetic nerve activity in response to hypotensive stress in the postural tachycardia syndrome","volume":"110","author":"Bonyhay","year":"2004","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/HYPERTENSIONAHA.106.076216","article-title":"Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure?","volume":"50","author":"Chappell","year":"2007","journal-title":"Hypertension"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.hrthm.2012.05.002","article-title":"Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome","volume":"9","author":"Coffin","year":"2012","journal-title":"Heart Rhythm"},{"key":"B5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"De Gasparo","year":"2000","journal-title":"Pharmacol. Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s10286-004-0188-9","article-title":"Segmental orthostatic fluid shifts","volume":"14","author":"Diedrich","year":"2004","journal-title":"Clin. Auton. Res"},{"key":"B7","first-page":"R817","article-title":"Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans","volume":"260","author":"Esler","year":"1991","journal-title":"Am. J. Physiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/NEJMcp074189","article-title":"Clinical practice. Neurogenic orthostatic hypotension","volume":"358","author":"Freeman","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.autneu.2011.02.004","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"161","author":"Freeman","year":"2011","journal-title":"Auton. Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF02281112","article-title":"Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone","volume":"10","author":"Freitas","year":"2000","journal-title":"Clin. Auton. Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/HYPERTENSIONAHA.110.151787","article-title":"Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome","volume":"56","author":"Fu","year":"2010","journal-title":"Hypertension"},{"key":"B12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.111.172262","article-title":"Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome","volume":"58","author":"Fu","year":"2011","journal-title":"Hypertension"},{"key":"B13","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.98.20.2154","article-title":"Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control","volume":"98","author":"Furlan","year":"1998","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1212\/01.wnl.0000267663.05398.40","article-title":"The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome","volume":"69","author":"Garland","year":"2007","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e000395","DOI":"10.1161\/JAHA.113.000395","article-title":"Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome","volume":"2","author":"Green","year":"2013","journal-title":"J. Am. Heart Assoc"},{"key":"B16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s10286-006-0373-0","article-title":"Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine","volume":"16","author":"Hoeldtke","year":"2006","journal-title":"Clin. Auton. Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1210\/jcem-73-1-132","article-title":"The orthostatic tachycardia syndrome: evaluation of autonomic function and treatment with octreotide and ergot alkaloids","volume":"73","author":"Hoeldtke","year":"1991","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"B18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0002-9343(99)80230-7","article-title":"Treatment of orthostatic tachycardia with erythropoietin","volume":"99","author":"Hoeldtke","year":"1995","journal-title":"Am. J. Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1210\/me.2004-0536","article-title":"Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II","volume":"20","author":"Hunyady","year":"2006","journal-title":"Mol. Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1056\/NEJM200010053431404","article-title":"The neuropathic postural tachycardia syndrome","volume":"343","author":"Jacob","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"B21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1152\/jappl.1998.84.3.914","article-title":"Effect of standing on neurohumoral responses and plasma volume in healthy subjects","volume":"84","author":"Jacob","year":"1998","journal-title":"J. Appl. Physiol"},{"key":"B22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/01.CIR.96.2.575","article-title":"Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia","volume":"96","author":"Jacob","year":"1997","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.HYP.32.4.699","article-title":"Raised cerebrovascular resistance in idiopathic orthostatic intolerance: evidence for sympathetic vasoconstriction","volume":"32","author":"Jordan","year":"1998","journal-title":"Hypertension"},{"key":"B24","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1540-8159.2011.03047.x","article-title":"Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience","volume":"34","author":"Kanjwal","year":"2011","journal-title":"Pacing Clin. Electrophysiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/MJT.0b013e3181ef621a","article-title":"Erythropoietin in the treatment of postural orthostatic tachycardia syndrome","volume":"19","author":"Kanjwal","year":"2012","journal-title":"Am. J. Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1540-8159.2008.02207.x","article-title":"Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and beta-blockers","volume":"32","author":"Lai","year":"2009","journal-title":"Pacing Clin. Electrophysiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0269881113512911","article-title":"Acute hemodynamic effects of a selective serotonin reuptake inhibitor in postural tachycardia syndrome: a randomized, crossover trial","volume":"28","author":"Mar","year":"2014","journal-title":"J. Psychopharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1152\/japplphysiol.00175.2007","article-title":"Reduced stroke volume during exercise in postural tachycardia syndrome","volume":"103","author":"Masuki","year":"2007","journal-title":"J. Appl. Physiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1161\/CIRCULATIONAHA.104.526764","article-title":"Decreased microvascular nitric oxide-dependent vasodilation in postural tachycardia syndrome","volume":"112","author":"Medow","year":"2005","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"H1226","DOI":"10.1152\/ajpheart.01243.2004","article-title":"Baroreflex control of muscle sympathetic nerve activity in postural orthostatic tachycardia syndrome","volume":"289","author":"Muenter","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.hrthm.2010.11.009","article-title":"Abnormalities of angiotensin regulation in postural tachycardia syndrome","volume":"8","author":"Mustafa","year":"2011","journal-title":"Heart Rhythm"},{"key":"B32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1161\/CIRCEP.111.965343","article-title":"Altered systemic hemodynamic and baroreflex response to angiotensin II in postural tachycardia syndrome","volume":"5","author":"Mustafa","year":"2012","journal-title":"Circ. Arrhythm. Electrophysiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"H664","DOI":"10.1152\/ajpheart.00138.2009","article-title":"Decreased upright cerebral blood flow and cerebral autoregulation in normocapnic postural tachycardia syndrome","volume":"297","author":"Ocon","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1161\/CIRCULATIONAHA.112.144501","article-title":"Postural tachycardia syndrome (POTS)","volume":"127","author":"Raj","year":"2013","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1161\/01.CIR.0000160356.97313.5D","article-title":"Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome","volume":"111","author":"Raj","year":"","journal-title":"Circulation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1161\/CIRCULATIONAHA.104.497594","article-title":"Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome","volume":"111","author":"Raj","year":"","journal-title":"Circulation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1161\/CIRCULATIONAHA.108.846501","article-title":"Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more","volume":"120","author":"Raj","year":"2009","journal-title":"Circulation"},{"key":"B38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0002-9629(15)40480-X","article-title":"The epidemic of orthostatic tachycardia and orthostatic intolerance","volume":"317","author":"Robertson","year":"1999","journal-title":"Am. J. Med. Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1042\/CS20130222","article-title":"A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome","volume":"126","author":"Ross","year":"2014","journal-title":"Clin. Sci. (Lond)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1152\/japplphysiol.00225.2005","article-title":"Cerebral autoregulation is preserved in postural tachycardia syndrome","volume":"99","author":"Schondorf","year":"2005","journal-title":"J. Appl. Physiol"},{"key":"B41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.43.1_Part_1.132","article-title":"Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia?","volume":"43","author":"Schondorf","year":"1993","journal-title":"Neurology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/hc0302.102597","article-title":"Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance","volume":"105","author":"Schroeder","year":"2002","journal-title":"Circulation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1056\/NEJM200002243420803","article-title":"Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency","volume":"342","author":"Shannon","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0306-4530(01)00002-6","article-title":"Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects","volume":"26","author":"Shores","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/01.wnp.0000229946.01494.4c","article-title":"Acetylcholinesterase inhibition in patients with orthostatic intolerance","volume":"23","author":"Singer","year":"2006","journal-title":"J. Clin. Neurophysiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1161\/01.CIR.0000016348.55378.C4","article-title":"Pooling in chronic orthostatic intolerance: arterial vasoconstrictive but not venous compliance defects","volume":"105","author":"Stewart","year":"2002","journal-title":"Circulation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1042\/CS20050254","article-title":"Increased plasma angiotensin II in postural tachycardia syndrome (POTS) is related to reduced blood flow and blood volume","volume":"110","author":"Stewart","year":"","journal-title":"Clin. Sci. (Lond)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"H665","DOI":"10.1152\/ajpheart.00784.2005","article-title":"Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome","volume":"290","author":"Stewart","year":"","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"H2749","DOI":"10.1152\/ajpheart.00429.2003","article-title":"Local vascular responses affecting blood flow in postural tachycardia syndrome","volume":"285","author":"Stewart","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1161\/01.CIR.0000040999.00692.F3","article-title":"Clinical and physiological effects of an acute alpha-1 adrenergic agonist and a beta-1 adrenergic antagonist in chronic orthostatic intolerance","volume":"106","author":"Stewart","year":"2002","journal-title":"Circulation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"H1319","DOI":"10.1152\/ajpheart.00086.2004","article-title":"Regional blood volume and peripheral blood flow in postural tachycardia syndrome","volume":"287","author":"Stewart","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.108.127357","article-title":"Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome","volume":"53","author":"Stewart","year":"2009","journal-title":"Hypertension"},{"key":"B53","doi-asserted-by":"publisher","first-page":"H466","DOI":"10.1152\/ajpheart.01139.2007","article-title":"Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome","volume":"294","author":"Stewart","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1042\/CS20070104","article-title":"Reduced body mass index is associated with increased angiotensin II in young women with postural tachycardia syndrome","volume":"113","author":"Stewart","year":"2007","journal-title":"Clin. Sci. (Lond)"},{"key":"B55","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1152\/jappl.2000.89.4.1505","article-title":"Vascular perturbations in the chronic orthostatic intolerance of the postural orthostatic tachycardia syndrome","volume":"89","author":"Stewart","year":"2000","journal-title":"J. Appl. Physiol"},{"key":"B56","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1152\/jappl.2001.90.6.2025","article-title":"Reflex vascular defects in the orthostatic tachycardia syndrome of adolescents","volume":"90","author":"Stewart","year":"2001","journal-title":"J. Appl. Physiol"},{"key":"B57","first-page":"326","article-title":"Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function: evidence for excessive venous pooling","volume":"111","author":"Streeten","year":"1988","journal-title":"J. Lab. Clin. Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1566-0702(00)00205-8","article-title":"Splanchnic-mesenteric capacitance bed in the postural tachycardia syndrome (POTS)","volume":"86","author":"Tani","year":"2000","journal-title":"Auton. Neurosci"},{"key":"B59","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-43-5-979","article-title":"Highly potent adrenal cortical steroids: structure and biologic activity","volume":"43","author":"Thorn","year":"1955","journal-title":"Ann. Intern. Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1161\/01.CIR.0000130847.18666.39","article-title":"Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles","volume":"109","author":"Vincent","year":"2004","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.peptides.2011.05.012","article-title":"New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine\/intracellular angiotensin II","volume":"32","author":"Zhuo","year":"2011","journal-title":"Peptides"}],"updated-by":[{"DOI":"10.3389\/fphys.2019.00978","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000}}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2014.00220\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T06:24:51Z","timestamp":1746253491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2014.00220\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,16]]},"references-count":61,"alternative-id":["10.3389\/fphys.2014.00220"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2014.00220","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,16]]},"article-number":"220"}}